Special poster session will include discussions, abstracts on HER2-low breast cancer research
SABCS Meeting News;

Nov 21st, 2022 - The advent of novel anti-HER2 therapies is not just improving treatment outcomes. These new targeted therapies are moving both pathologists and clinicians to rethink the basic concepts of HER2 breast cancers. “For two decades, we have thought in terms of HER2+ and HER2- breast cancers based on widely accepted assays, cutoff points, and treatment guidelines,” said Kalliopi P. Siziopikou, MD, ...

Panel of experts to discuss approaches and innovations to overcome ‘big obstacles’ in breast cancer
SABCS Meeting News;

Nov 21st, 2022 - Struggles are nothing new in health care, and breast cancer research and care are no exceptions. The Program Planning Committee for the San Antonio Breast Cancer Symposium (SABCS) recognized that moving forward requires identifying and discussing our biggest obstacles. The Special Session Overcoming the Big Obstacles to Find Solutions for Breast Cancer, 12:00 pm – 2:00 pm CT, Tuesday, December ...

Novel approaches are helping patients live longer, and live better, with metastatic breast cancer
SABCS Meeting News;

Nov 21st, 2022 - The reality that more women are living longer with breast cancer is a testament to the growing success of treatment. It is also a challenge. More women living longer with breast cancer is moving clinicians, researchers, and patient advocates to find ways to help breast cancer survivors live not just longer, but better.

Special Session will focus on health equity and how ‘big data’ can impact outcomes
SABCS Meeting News;

Nov 21st, 2022 - Electronic medical records, and the data they provide, are often at the center of discussion about data sharing, privacy, and consents. Those records are goldmines for companies digging for data that can be used for profit and commercialization. Underrepresented minorities are more often the subject of unconsented data sharing but, conversely, frequently are left out of the equation when data i...

Advocacy study one of the posters for #SABCS22

Oct 24th, 2022 - Twitter lit up this week as submitters were notified their abstracts has been accepted for presentation at the 45th annual San Antonio Breast Cancer Symposium. One of those celebrating the news was Mya Roberson, MSPH, PhD, an assistant professor in the department of Health Policy at the Vanderbilt University School of Medicine in Nashville, Tenn. She will present her research on the impact p...

Highlights from the Program Committee

Oct 10th, 2022 - From plenary and award lectures delivered by some of the top thought-leaders and pioneers in breast cancer research and care to late-breaking and practice-changing findings from some of the most cutting-edge research being conducted in the field, the SABCS 2022 Program Committee has outdone itself in assembling a robust program with something for everyone.

SABCS 2022 Symposium Overview

Sep 26th, 2022 - This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. The scientific program consists of formal lectures by experts in clinical and basic research, selected slide and poster ...

SABCS 2022 Frequently Asked Questions (FAQs)

Sep 26th, 2022 - Symposium Information, Program Schedule, Registration, Abstract Submission, Housing Instructions, Food & Beverage, Media Section, Abstracts On-line, About SABCS, Scholarships, Travel & Transportation

SABCS Call for Abstracts 2022

Sep 26th, 2022 - Call for Abstracts for the 2022 San Antonio Breast Cancer Symposium is now closed. The Abstract Submission deadline for regular abstracts is closed The 2022 SABCS Late Breaking Abstract submission site is now open. The deadline to submit a late breaking abstract is September 30, 2022 Presenters of accepted abstracts for oral presentations, spotlight poster presentations and poster presen...

2022 SABCS Prospectus
https://www.sabcs.org/Portals/SABCS2016/2022 SABCS/2022 SABCS Prospectus.pdf?ver=2022-06-07-075413-297

Sep 26th, 2022 - UT Health San Antonio and the American Association for Cancer Research take great pride in presenting the San Antonio Breast Cancer Symposium which will take place December 6–10, 2022, at the Henry B. Gonzalez Convention Center.

SABCS 2022

Sep 1st, 2022 - SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

Committee reviewing more than 1,600 abstracts

Sep 1st, 2022 - More than 600 universities, research laboratories, pharmaceutical companies, and national cancer centers from around the world have submitted 1,667 abstracts for consideration for the 45th annual San Antonio Breast Cancer Symposium. A global programming committee of 90 will review each of those abstracts. The goal is to narrow the submissions so attendees will have access to the most balance...

SABCS 2022 Meeting News

Aug 31st, 2022 - Alongside the newest research findings and breast cancer therapies, this year’s program includes “Controversies” sessions covering some of the most-talked about topics, a special session on diversity, and more.

SABCS Preliminary Program 2022

Aug 31st, 2022 - Most of the presentations at SABCS focus on the latest clinical and basic research results relating to breast cancer. By contrast, educational sessions are designed to inform and update those interested in a review on a particular topic. Although these sessions may include new specific research findings, their primary intent is to offer summaries of existing knowledge, and to provide background...

SABCS PODCAST Series – 2022

Aug 31st, 2022 - UT Health San Antonio's Continuing Medical Education (CME) 2022 Breast Cancer Translated podcast series is an up and coming educational podcast where hot topics in medicine, healthcare, and education will be discussed with world leading physicians and scientists. Through this podcast series, our experts will explore the rapidly changing nature of current issues through robust conversations idea...

View from the Trenches: Key clinical practice takeaways from #SABCS21

Dec 13th, 2021 - Stephen RD Johnson, MS, PhD The final session of SABCS is always one of the most popular programs of the week, View from the Trenches: What Will You Do on Monday Morning? The session featured a multidisciplinary panel of experts discussing some of the most important breast cancer results from the meeting and putting the findings into context for day-to-day clinical practice. HR+ Early Breast Ca...

Year in Review: Panelists summarize key findings in breast cancer research in 2021

Dec 13th, 2021 - Despite the ongoing challenges of COVID-19 over the past year, researchers in 2021 reported important progress and major discoveries in breast cancer. A panel of experts discussed some of the latest advances in early and advanced breast cancer, basic science, and translational research during the special session Year in Review on Friday, December 10 at SABCS 2021. This and other SABCS sessions ...

Plenary lecturer highlights advancements, emerging treatments in TNBC

Dec 13th, 2021 - Lisa A. Carey, MD, ScM In her plenary lecture on Friday at SABCS 2021, medical oncologist Lisa A. Carey, MD, ScM, discussed Triple Negative Breast Cancer: Pitfalls & Progress, including advancements in treatment options and implications for population health. Dr. Carey is the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research at the University of North Caroli...

Researcher reviews progression of genetic profiling during plenary lecture

Dec 13th, 2021 - Mitchell Dowsett, PhD, FMedSci Genetic profiling has been an active area of breast cancer research for more than 20 years. And while genetic profiling has become a useful clinical tool, it remains an inexact science. “That first paper did not describe the subtypes we have become very used to using ― the luminal subtypes, the basal subtype, ErbB2+ subtypes,” said Mitchell Dowsett, PhD, FMedSci, ...

Studies looking at impact of race on breast cancer severity and outcomes presented at #SABCS21

Dec 11th, 2021 - Andrea Barrio, MD Black Women are More Likely to Develop Lymphedema Following Breast Cancer Treatment than White Women Black women experienced higher rates of breast cancer-related lymphedema than white women, and Black race was the strongest predictor of lymphedema development, according to study results presented during Friday’s General Session. “Lymphedema worsens quality of life for breast ...